← FDA DRUG APPROVALS

FDA ANDA · ANDA065503

CEFUROXIME SODIUM

Sponsor: HOSPIRA INC

APPLICATION
ANDA065503
TYPE
ANDA
ORIGINAL APPROVAL
2008-10-15
LATEST ACTION
2016-05-20
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

CEFUROXIME SODIUMDiscontinued
CEFUROXIME SODIUM EQ 1.5GM BASE/VIAL · INJECTABLE · INJECTION

Approval history

2016-05-20Labeling · Supplement 2 · standardAP
2008-10-15OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →